Navigation Links
Reportlinker Adds Ophthalmology DrugFutures
Date:4/21/2011

.

The current standard of care for wet AMD is Lucentis (ranibizumab), marketed by Roche in the US and Novartis elsewhere. Growth has been impressive since its launch in 2006; global sales amounted to US$3 billion in 2010. The cost of treatment is high, however, and there is some competition from off-label use of Roche's Avastin (bevacizumab), which is significantly cheaper. In the US, the National Eye Institute is conducting a major Phase III comparative study of Avastin and Lucentis for the treatment of AMD.

But there is new competition expected on the market. The most advanced developmental treatment for AMD is Bayer and Regeneron's VEGF Trap-Eye. Following positive top-line results from Phase III trials, regulatory filings have been planned in the US and EU in 2011. If approved, it is expected that this product will be quickly taken up in the market-place. It appears to have similar efficacy to Lucentis with less frequent dosing, which is likely to prove popular among patients and healthcare providers alike.

The report covers

Market analysis

What is macular degeneration?

How is it treated?

Photodynamic Therapy

Anti-VEGF

Why are new treatments needed?

What is in development?

AMD prevalence

Launched products

Lucentis (ranibizumab)

Macugen (pegaptanib)

Visudyne (verteporfin)

Phase III

VEGF Trap-Eye

Phase II

ACU-4429

PF-4523655

GLAUCOMA

Glaucoma affects around 65-70 million people worldwide and is the second leading cause of blindness, after cataracts. The WHO estimates that glaucoma was responsible for around 12.3% of world blindness in 2002, affecting around five million people.

Undoubtedly, generic companies will claim a significant share of the US$4.9 billion glaucoma market over the next few years. Pfizer's US patent for the market leader, Xalatan (latanoprost) expired in March 2011
'/>"/>

SOURCE S ....... 118
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Reportlinker Adds Europe ENT Devices Market Outlook to 2017
2. Reportlinker Adds Medical Equipment Annual Deals Analysis 2011
3. Reportlinker Adds Gastric Cancer Drug Discoveries: what the future holds
4. Reportlinker Adds the Drug-Eluting Stent Market Outlook to 2016
5. Reportlinker Adds Successful Strategies for Drug Repositioning
6. Reportlinker Adds Middle Eastern Medical Device Market: Facts and Figures2011
7. Reportlinker Adds Levosimendan - Comprehensive patent search
8. Reportlinker Adds Zolpidem - Key patent, SPC, and data exclusivity expiry (44 country coverage)
9. Reportlinker Adds North America Dental Devices Market Outlook to 2017
10. Reportlinker Adds ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
11. Reportlinker Adds ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014  Paper Pak Industries, a ... APLS ® Body Guard Bio, a disposable, ... of bacteria and virus while protecting service providers ... Bio features a rugged, external nylon shell, watertight ... a leak-proof inner chamber that contains contaminated and ...
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)... 2014   Surefire Medical , Inc., the developer ... maximize targeted delivery of embolization agents in minimally invasive ... John R. Daniels , MD of the University ... oncologist Steven C. Katz , MD of the ... Advisory Board (SAB).    "The role of ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
... SHENZHEN, China, July 24, 2011 /PRNewswire-Asia/ -- Benefited by ... care products, more and more people are inclined to ... and for their families as an indispensable device to ... future, several trends will be followed. Customer,s needs and ...
... RNL Natural Co., Ltd, a leading biotech company specialized ... Ltd., introduced on June 22, 2011 a new method of ... breath VOCs (volatile organic compounds, a predictor of breast cancer). ... women diagnosed with breast cancer and 35 healthy women not ...
Cached Medicine Technology:Free Delivery on All Health Care Products 2A Simple Way to Detect Breast Cancer at 'Stage 0' Discovered 2
(Date:10/22/2014)... October 22, 2014 The ... which is dedicated to distribute health information technology ... delivery worldwide announced the development of six key ... expect when receiving healthcare. These are an expansion ... care: “providing care that is respectful of and ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the most ... recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the ... the world. , “iPower is one of the most ... various kinds of useful products for new and old ... customer service and a number of features which will ...
(Date:10/22/2014)... CA (PRWEB) October 22, 2014 Lintelus, ... Cormier, Sr. Vice President of Sales, will be speaking ... upcoming Meetings Technology Expo on October 28, at the ... be hosting a booth as well as a Tech ... Lintelus Meeting can create a more engaging event experience. ...
(Date:10/22/2014)... Salamon HealthDay Reporter , TUESDAY, ... vitro fertilization (IVF) are only about half as likely as ... technique, new research indicates, and the racial disparity persists even ... 31 percent of white patients became pregnant after IVF, compared ... than 4,000 IVF cycles over two years to tease out ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
Breaking Medicine News(10 mins):Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... and EAST WINDSOR, N.J., Nov. 1, Warner Chilcott ... WCRX]) and NexMed, Inc. (Nasdaq: NEXM ),announced ... a licensing,agreement granting Warner Chilcott the exclusive U.S. ... treatment of erectile,dysfunction (ED). NexMed submitted a New ...
... help humans, team says , THURSDAY, Nov. 1 (HealthDay News) ... canine coat color, and the discovery could have implications for ... of Medicine says the finding may help lead to a ... have varying abilities to cope with stress. , They analyzed ...
... Assistant Professor of Surgery, Section of Vascular Surgery, at ... of Medicine, is the lead author of a research ... carotid artery occlusive disease should have carotid surgery or ... of the aortic arch that could help explain why ...
... They,re more likely to skip care because of costs ... 1 (HealthDay News) -- Although the United States spends ... other western countries, many Americans say they are forced ... errors, and say the health-care system needs to be ...
... Million ... Americans, ... VNUS ), a worldwide leader in medical devices,for the minimally invasive ... market growth of the VNUS,ClosureRFS(TM) Stylet, an endovenous radiofrequency (RF) ablation ...
... the Handicapped Association (NARHA) awards,Ashaway,s horse-assisted rehabilitative therapy with Premier ... ... Accreditation, ASHAWAY, R.I., Nov. 1 Turning Pointe,Therapeutic Riding ... North American Riding for the Handicapped Association (NARHA),the national standard ...
Cached Medicine News:Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 2Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 3Health News:Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction 4Health News:Scientists Spot Dog Fur Color Gene 2Health News:Research sheds light on carotid artery stenting risk in elderly 2Health News:Research sheds light on carotid artery stenting risk in elderly 3Health News:Many Americans Dissatisfied With Their Medical Care 2Health News:Many Americans Dissatisfied With Their Medical Care 3Health News:Many Americans Dissatisfied With Their Medical Care 4Health News:Physicians Hail VNUS Device for Closing Diseased Perforating Veins 2Health News:Physicians Hail VNUS Device for Closing Diseased Perforating Veins 3Health News:Turning Pointe Therapeutic Riding Recognized for Excellence in Providing Equine-Assisted Therapies to People with Disabilities 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: